GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » ROC %

Curative Biosciences (Curative Biosciences) ROC % : -27.32% (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Curative Biosciences's annualized return on capital (ROC %) for the quarter that ended in Mar. 2018 was -27.32%.

As of today (2024-05-27), Curative Biosciences's WACC % is 0.00%. Curative Biosciences's ROC % is 0.00% (calculated using TTM income statement data). Curative Biosciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Curative Biosciences ROC % Historical Data

The historical data trend for Curative Biosciences's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences ROC % Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -365.94 -189.11 -421.76 -336.11 -11.98

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.14 -17.29 -16.35 -470.22 -27.32

Curative Biosciences ROC % Calculation

Curative Biosciences's annualized Return on Capital (ROC %) for the fiscal year that ended in Jun. 2017 is calculated as:

ROC % (A: Jun. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2016 ) + Invested Capital (A: Jun. 2017 ))/ count )
=-0.053 * ( 1 - 0% )/( (0.438 + 0.447)/ 2 )
=-0.053/0.4425
=-11.98 %

where

Curative Biosciences's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2018 is calculated as:

ROC % (Q: Mar. 2018 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2017 ) + Invested Capital (Q: Mar. 2018 ))/ count )
=-0.128 * ( 1 - 0% )/( (0.384 + 0.553)/ 2 )
=-0.128/0.4685
=-27.32 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2018) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biosciences  (OTCPK:CBDX) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Curative Biosciences's WACC % is 0.00%. Curative Biosciences's ROC % is 0.00% (calculated using TTM income statement data). Curative Biosciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Curative Biosciences ROC % Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines